Aballi John

Aballi John is listed in filings as President and CEO at Exagen Inc.. This profile follows SEC Form 4 activity through Mar 16, 2026, including sale activity and purchase activity. Recent filings connect the profile to Exagen Inc. (XGN). The current snapshot covers public activity from Nov 18, 2024 to Mar 16, 2026. Reported amounts are shown as $316.0K to $7.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.